Brief: Intec Pharma Reports Q2 Loss Per Share $0.05

Indaptus Therapeutics

05/08/2020 13:05

Aug 5 (Reuters) - Intec Pharma Ltd  NTEC.O :
    * INTEC PHARMA REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS
AND
PROVIDES CORPORATE UPDATE
    * Q2 LOSS PER SHARE $0.05
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.05 -- REFINITIV IBES
DATA
    * AT THIS TIME, WE DO NOT ANTICIPATE COMPOUND ENTERING AN IN
VIVO
STUDY THIS YEAR
    * CONTINUE TO DISCUSS DEVELOPMENT OPPORTUNITIES FOR
ACCORDION PILL
WITH MERCK

Source text for Eikon:  ID:nPn5JnTnKa 
Further company coverage:  NTEC.O 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))